2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene has been researched along with ryanodine in 1 studies
Studies (2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene) | Trials (2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene) | Recent Studies (post-2010) (2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene) | Studies (ryanodine) | Trials (ryanodine) | Recent Studies (post-2010) (ryanodine) |
---|---|---|---|---|---|
14 | 0 | 0 | 2,894 | 3 | 237 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Coghlan, JP; Denton, DA; Hardy, KJ; Johnson, EI; McDougall, JG; Scoggins, BA; Wright, RD | 1 |
1 other study(ies) available for 2-n-propyl-3-dimethylamino-5,6-methylenedioxyindene and ryanodine
Article | Year |
---|---|
Ca antagonists do not alter aldosterone secretion during established Na depletion.
Topics: Adrenal Glands; Aldosterone; Animals; Calcium; Calcium Channel Blockers; Dose-Response Relationship, Drug; Edetic Acid; Female; Gallopamil; Hydrocortisone; Indenes; Ion Channels; Lanthanum; Nifedipine; Nisoldipine; Ryanodine; Sheep; Sodium; Verapamil | 1985 |